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During performance of activities that emphasize anaerobic
glycolysis to generate energy, a reduction in performance is
generally associated, in part, with lactacidosis. As lactate
levels rise during the performance of the activity, pH and
bicarbonate levels decrease. Strategies designed to buffer lactic
acid (LA) have demonstrated ergogenic potential for both sodium
bicarbonate (NaHCO3) and sodium citrate during activities
ranging from 1 to 2 minutes' in duration. The purpose of the
present study was to determine if these buffering agents
exhibited ergogenic potential during high intensity activity of 4
to 6 minutes duration. Subjects were 7 male and 5 female
trained track athletes between the ages of 18 and 33. Each
subject participated in a total of 4 competitive 1600 meter
races, each scheduled at least 3 days apart. Subjects ingested a
treatment (0.4 g/kg NaHCO3 or 0.5 g/kg sodium citrate) or
placebo (calcium carbonate) 2 hours prior to three of the races;
one race was used as a control. The order in which the races
were run was counter-balanced and randomly assigned. Blood
Redacted for Privacylactate, pH, and bicarbonate levels were measured prior to and 
immediately following each race. Following the completion of 
the race, the subjects reported on physical symptoms of 
gastrointestinal (GI) discomfort they experienced during the run. 
Means and standard deviations for performance times (in sec) 
were not different under any condition: HCO3 (319.2, 30.1); 
Citrate (321.1, 24.1); Placebo (319.9, 27.3); Control (319.8, 27.0). 
There was an exercise, but no treatment effect on blood lactate, 
but there was an exercise and treatment effect on pH and 
bicarbonate. NaHCO3 ingestion resulted in more severe symptoms 
of GI discomfort than any other condition, and ingestion of 
sodium citrate led to the greatest number of complaints of GI 
discomfort.  It  is concluded that the buffering agents had no 
effect on racing time and that bicarbonate loading is associated 
with uncomfortable side effects in many athletes. 
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 CHAPTER I 
INTRODUCTION 
Tsaneva and Markov (1971) described fatigue as a process and 
defined this process as a complex phenomenon caused by the 
working state of a biological system, influenced by many 
external and internal factors. Grandjean and Kogi (1971) referred 
to fatigue as a group of phenomena associated with impairment 
or loss of efficiency in the performance of a skill, as well as the 
development of anxiety, frustration, or boredom. Bates, Osternig, 
and James (1977) attempted to define fatigue as a process that 
affects the organization of movement, while Edwards (1981) 
defined it as a failure to maintain an expected force output. 
Schmidt (1968) described fatigue as a performance variable 
which temporarily decreases the level of proficiency of the 
performance. All these studies agree that a decrement in 
performance of the skill occurs with fatigue. 
During activities of daily living, fatigue simply represents an 
irritant.  It may necessitate a reduction in or stoppage of the 
activity in order to recover from the preceding work. However, 
with the exception of disease states,  it does not have prolonged 
negative consequences. In the realm of competitive athletics 
however, success is determined by performance outcomes. An 
individual whose performance is hindered by fatigue may 
discover that he or she loses an important race, loses a position 2 
on a team, loses some type of award, and, in some instances, it 
represents economic loss. Under these circumstances, it  is not 
surprising that methods to delay the onset of fatigue during all 
types of sport are being extensively researched. 
The research can be differentiated by the type and intensity 
of the exercise being performed. Different methods to replenish 
adenosine triphosphate (ATP) and delay the onset of fatigue are 
used during exhaustive exercise activities as compared to 
endurance activities. ATP is the main source of fuel that the 
body utilizes, and different metabolic pathways exist to 
generate energy necessary to power the activity. The pathways 
which are emphasized depend on the functional demands of the 
situation. Therefore, the mechanism of fuel delivery and fuel 
supply used during high intensity anaerobic activities differs 
greatly from that of sub-maximal aerobic activities. 
During brief exhaustive activity, the energy supply comes 
from the breakdown of nutrients stored within the muscle fiber. 
This is referred to as the ATP-creatine phosphate (CP) system. 
The configuration of this system permits rapid production of 
ATP, but it  is not capable of supplying the energy required for 
most activities. Since the CP supply and storage capacities of CP 
are limited, energy becomes depleted in a matter of a few 
seconds. 
During heavy exercise exceeding a few seconds in duration 
and lasting up to approximately three minutes in duration, 
anaerobic glycolytic processes predominate to supply the energy. 
This involves the incomplete combustion of carbohydrates 3 
obtained via dietary intake. During this breakdown process, 
lactic acid (LA) is produced. Lactic acid is a strong acid which 
can accumulate in the muscle. Excessive accumulation of LA has 
been implicated in the onset of fatigue and reduction in 
performance in this type of activity. When the rate of LA 
production exceeds the rate of LA clearance, LA accumulates. LA 
accumulation in the muscle may interfere with the contractile 
mechanism of the muscle (Mainwood and Worsley-Brown, 1975; 
Linderman and Fahey, 1991), it may stimulate pain receptors, and 
it may slow glycolysis (Goldfinch, Mc Naughton, and Davies, 
1988). All of these effects can lead to a decrease in 
performance. 
During prolonged activity, multiple metabolic pathways can 
be involved in the production of ATP. Although a considerable 
amount of ATP can be generated via these pathways, it cannot be 
resynthesized as quickly. Also in this system, LA does not 
accumulate, as it  is cleared as quickly as it  is produced. For 
activities that are neither purely anaerobic in nature, nor 
prolonged sub-maximal aerobic work, such as the 1600 meter 
race, a blending of metabolic pathway activity occurs to supply 
energy. Performance of this event, which is classified as a 
sustained speed event, results in LA accumulation. It is the LA 
accumulation which appears to be a major contributor to the 
reduction in performance during activities of this type. 
Fox and Mathews (1981) suggest that in a race of this 
distance, anaerobic glycolytic pathways predominate by 
contributing approximately 55% to the total energy production. 4 
Oxidative pathways contribute approximately 25%, and stored 
phosphagens the remaining 20%. In an event performed at this 
level of intensity for a duration of 4-6 minutes, increasing 
levels of LA in the muscle and blood become a factor in the 
performance. Since the intensity of the performance easily 
reaches 100% VO2 max during this type of racing situation, LA 
accumulates (Farrell, Wilmore, Coyle, Billing, and Costill, 1979). 
For each of these situations, extensive volumes of research 
have focused on methods to delay the onset of fatigue. The 
rationale being that if one is able to postpone the onset of 
fatigue, the athlete would be able to perform at that higher 
intensity for a longer portion of the event. This may enable the 
participant to complete the event before succumbing to fatigue. 
Methods and techniques designed to enhance performance are 
referred to as ergogenic aids. This term is broad and may 
incorporate the use of procedures, use of exogenous substances 
and nutritional supplements, manipulation of the normal state of 
the energy systems within the body, or manipulation of the 
normal physiological response to the activity in order to enhance 
performance. 
Specificity and intensity of training is one method which may 
serve to enhance performance in activities emphasizing 
anaerobic glycolysis. Additionally, the body has a number of 
inherent buffering systems which function to assist in 
neutralizing the strong acids and postpone the presence of the 
acidic environment. Of these, the bicarbonate ion (HCO3) system 
is the major buffer in the blood (Parry-Billings and Mac Laren, 1986). This carbonic acid-bicarbonate system functions 
effectively in the body to buffer lactic acid.  If the hydrogen ion 
concentration increases in the blood, which is observed when LA 
accumulates, a corresponding decrease in bicarbonate ion 
concentration is noted. This is a result of more carbonic acid 
being formed. This buffering system functionS to assist in 
maintaining the acid-base relationship near an optimal point, 
which is  critical  for homeostasis. 
In situations such as heavy exercise, activity of these 
inherent buffering systems alone may not be adequate. Ingestion 
of substances such as sodium bicarbonate (NaHCO3) or sodium 
citrate has been utilized by athletes during exercise in an 
attempt to enhance the buffering of LA. It  is thought that by 
preventing acidosis brought on by the formation of LA, one is 
able delay the onset of fatigue. Results from several studies 
suggest that buffering may function effectively as an ergogenic 
aid during heavy exercise lasting from one to four minutes in 
duration (Wilkes, Gledhill, and Smyth, 1983; Goldfinch et al., 
1988). In these studies of 400 and 800 meter running races, 
participants were able to demonstrate faster run times 
following ingestion of a substance which had an alkalizing effect 
on the blood. 
Results from studies involving events of less than 30 seconds 
duration suggest that in these types of events the amount of LA 
production had not peaked, and the maximal buffering capacity 
was not utilized to enhance performance (Inbar et al., 1983). 
Likewise, results from studies of continuous exercise lasting 6 
longer than 10 minutes in which alkalizing substances were 
ingested were inconclusive (Johnson and Black, 1953).  Plausible 
explanations for these results include, less reliance on anaerobic 
glycolysis to generate energy during the longer runs. Since 
oxidative processes predominate, significant LA accumulation 
may not have occurred, thus making buffering unnecessary. 
The effects of ingestion of sodium bicarbonate, known as 
"bicarbonate loading" on anaerobic performance have been studied 
to a greater extent than have the effects of ingestion of citrate 
or "citrate loading". The results indicate that bicarbonate loading 
using a dose equal to or greater than 0.3 g/kg body mass may 
result in improved performance in events that emphasize the LA 
system to produce ATP (Kindermann, Keul, and Huber, 1977). 
However, the high doses necessary to enhance performance may 
also cause symptoms of gastrointestinal (GI) discomfort, such as 
diarrhea and nausea (Gledhill, 1984; Goldfinch, et al., 1988). 
Although not studied extensively, citrate ingestion has also 
been suggested as an ergogenic aid for performance in high 
intensity events ranging from 100 to 400 meters (Hewitt and 
Calloway, 1936). Parry-Billings & Mac Laren (1986) found citrate 
ingestion to be more effective than a comparable dose of 
bicarbonate in delaying fatigue associated with lactacidosis. 
Additionally, citrate loading has not resulted in the 
gastrointestinal distress noted with large doses of bicarbonate 
(Mc Naughton, 1990). 
Level of training of the subjects, dosage administered, and 
point in time of ingestion prior to the competition are all factors 7 
in the use of exogenous substances to enhance performance that 
appear to be crucial to the outcome. Trained individuals who 
ingest doses of sodium bicarbonate equal to or greater than 0.3 
g/kg of body mass 90-120 minutes prior to the event enjoy the 
greatest potential for enhanced performance if the event is 1-4 
minutes in duration (Bouissou, Estrade, Goubel, Guezennec, and 
Serrurier, 1989; Williams, 1992). In an effort to minimize the 
potential for GI distress, the sodium bicarbonate is frequently 
ingested with approximately one liter of water. Mc Naughton 
(1990) identified the sodium citrate dose with the greatest 
ergogenic potential as 0.5 g/kg for similar types of activity. 
Due to the potential for undesirable symptoms of 
gastrointestinal distress when using certain buffering agents,  it 
is important to determine if there is an ergogenic agent which is 
equally effective in this role without yielding the undesirable 
side-effects. The 1600 meter racing distance is a highly 
competitive event with performance outcomes carrying enormous 
consequences for some participants. With outcomes being 
determined by mere seconds, there is a strong desire and need to 
identify all the factors which can be influenced to lead to 
improved performance. These factors may include the 
determination of a balance between desirable improvements and 
undesirable side-effects.  If one substance can demonstrate a 
decided advantage over others to accomplish this,  it would be the 
ergogenic aid of choice. 8 
Statement of Problem 
The purpose of the present study was to determine the 
effects on performance in a competitive 1600 meter run 
following ingestion of selected buffering agents in trained track 
athletes. Previous studies suggest that in this event lactacidosis 
plays a major role and influences performance in part via 
fatigue. By minimizing the acidic environment, performance may 
be enhanced in this event. 
The selected biochemical agents included: 
1.  sodium bicarbonate 
2.  sodium citrate 
3.  placebo (calcium carbonate) 
The parameters selected for analysis included: 
1.  run time 
2.  blood lactate level 
3.  blood pH level 
4.  blood bicarbonate level 
5.  subjective symptom scale 
Hypotheses 
1.  following ingestion of the buffering agents, performance 
will be significantly enhanced as measured by faster run times 
compared to the placebo and control conditions. 9 
2.  at the completion of the run, following ingestion of the 
buffering agents, blood pH levels will be significantly higher 
compared to the placebo and control conditions. 
3.  at the completion of the run, following ingestion of the 
buffering agents, blood lactate levels will be significantly 
higher compared to the other conditions. 
4.  at the completion of the run, following ingestion of the 
buffering agents, blood bicarbonate levels will be significantly 
higher compared to the placebo and control conditions. 
5.  ingestion of sodium citrate will result in significantly 
fewer gastrointestinal side-effect symptoms compared to 
sodium bicarbonate ingestion. 
6.  ingestion of sodium citrate will result in  significantly 
faster race times than all other conditions. 
Delimitations 
The population chosen for analysis consisted of competitive 
male and female track athletes, ages 18 to 33. All male runners 
were able to complete a 1600 meter race in less than 5 minutes. 
Females were capable of completing this distance in less than 6 
minutes. 10 
Limitations
 
I.  subjects were obtained via a sample of convenience and 
may not be representative of the track running population at 
large. 
2.  subjects may have made assumptions as to the substance 
ingested, which may have influenced performance. 
3.  subjects were not required to race during inclement 
weather conditions. 
4.  subjects were encouraged to maintain their normal routine 
concerning exercise, sleep, and eating habits in the 24 hours 
previous to data collection in attempt to control for fatigue 
and/or motivational  level. 
Definition of terms 
Fatigue.  Fatigue is defined in this study as an increase in the 
performance time of the 1600 meter run. 
Alkalosis. Alkalosis is defined in this study as a venous pH 
blood value exceeding 7.35. 
Buffering. Buffering is defined in this study as the chemical 
reactions that occur in an effort to minimize changes in the 
concentration of hydrogen ions. 
Loading. Loading is defined in this study as ingestion of a 
substance which will alter the normal physiological response to 
exercise in a manner which may enhance performance. 11 
VO2max In this study, VO2 max is defined as the point at 
which oxygen consumption plateaus or decreases despite 
increasing workloads. 12 
CHAPTER II 
REVIEW OF LITERATURE 
Metabolism 
The performance of an activity requires the expenditure of 
energy. In order to accomplish this, an energy supply must be 
available. Adenosine triphosphate (ATP) is the fuel that humans 
utilize to power the muscular activity. There are several 
methods available within the body, capable of generating ATP. A 
relationship exists between the intensity and the duration of the 
exercise which dictates how the energy will be made available. 
During brief intense activity, the energy is supplied via stored 
nutrients found within the muscle fiber. These nutrients, ATP 
and another high energy phosphate, creatine phosphate (CP), are 
able to be used immediately as a source of energy. Because the 
nutrients are stored in the muscle fiber and only one biochemical 
step is required, this mechanism permits rapid ATP generation. 
Despite the speed of ATP production yielded from this process, 
the CP supply and storage capacities are limited. Activities of 
all out effort can only be sustained for approximately 5-6 
seconds, as these CP stores become rapidly depleted (Williams, 
1992). 
Once the CP stores become depleted, a switch to other 
sources for the generation of energy must occur to supplement 13 
the energy supply, or else the activity needs to terminate. 
Glycolytic pathways for energy production become active to 
supplement and allow for continuation of the activity. Anaerobic 
glycolysis involves the incomplete combustion of carbohydrates 
obtained via dietary intake. This allows for rapid production of 
ATP, but deleterious metabolic end products are formed. 
Increases in the concentration of the end product lactic acid (LA) 
result in increases in hydrogen ion (H+) concentrations 
(Kindermann et al., 1977; Goldfinch et al., 1988; Linderman & 
Fahey, 1991; Williams, 1992). During this breakdown process, the 
normal acid-base balance of the body is disrupted, resulting in 
acidosis. At rest, arterial blood tends to be in a neutral or 
slightly alkalotic state, with a pH of approximately 7.4 
(Williams, 1992). At rest, venous blood is approximately 7.35, 
and muscle pH is approximately 6.9 (Linderman & Fahey, 1991). 
During heavy activity, they all become more acidic, and pH 
decreases. 
Lactic acid is a strong acid which, under certain conditions, 
may accumulate in the muscle and blood. Along with the 
increased LA concentration, decreases occur in pH and 
bicarbonate (HCO3) concentration, attributable to the LA formed 
from the preceding exercise (Hermansen and Osnes, 1972). 
Excessive accumulation of LA has been implicated in the onset of 
fatigue and reduction in performance (Sutton, Jones, and Toews, 
1981). Brooks (1985) indicates that when the rate of LA 
production exceeds the LA clearance rate, this metabolite 
accumulates. Numerous researchers (Asmussen, 1979; Linderman 14 
& Fahey, 1991; McKenna, 1992; and Sahlin, 1992) indicate that 
with LA accumulation comes acidosis and a decrease in pH, which 
may stimulate pain receptors and interfere with muscle 
contractile protein function. 
Reduction in excitation-contraction coupling secondary to 
decreased calcium (Ca++) activation has been suggested as a 
contributing factor to fatigue. Cross-bridge formation may be 
impaired, resulting in a decrease in the amount of tension 
produced. Fuchs, Reddy, and Briggs (1970) indicate that elevated 
H+ levels may compete with Ca++ for binding sites on the 
troponin molecule. Other researchers (Nakamaru and Schwartz, 
1972; Fabiato and Fabiato, 1978) indicate that elevated H+ may 
alter the normal conformational structure of the tropomyosin 
molecule. They also suggest that this may decrease the number 
of actin and myosin cross-bridge interactions leading to a 
reduction in the amount of tension which can be developed. 
Goldfinch et al. (1988) report that this may slow glycolysis by 
inhibiting key enzyme activity. Activity of the rate limiting 
enzyme phosphofructokinase (PFK) has been demonstrated to 
decrease as H+ levels rise. This slows the velocity of ATP 
production. All these factors lead to a decrease in performance. 
Sjogaard (1986) analyzed individuals during the performance 
of maximal and sub-maximal activities. The individuals 
participated  in various activities involving the lower 
extremities, and specific ionic and water levels were evaluated 
for change from the pre-test to post-test condition. Blood was 
collected from the femoral vein. During the maximal condition in 15 
all activities, a decrease in muscle pH and accumulation of LA 
was noted, and a slowing of glycolysis occurred. Homeostasis 
was disrupted, causing the force-generating capacity of the 
muscle to become temporarily inadequate. When this happens, 
activity must either decrease in intensity or terminate. 
Natural buffering systems exist within the body to help 
neutralize the strong acids produced during metabolism. 
Buffering refers to the chemical reactions which occur to 
minimize increases in hydrogen ion concentration. A buffering 
system consists of a weak acid and the salt of that acid. During 
heavy exercise, LA accumulates in the muscle, creating  an acidic 
environment. Although there are some mechanisms within the 
muscle to assist in buffering H+, most of the buffering  occurs 
within the extracellular fluid component of the body. 
Extracellular buffering serves to alkalize the bodily fluid and 
enhance the lactate and H+ efflux from the muscle into the blood 
(Goldfinch et al., 1988). As this happens, the blood bicarbonate 
(HCO3) levels decrease proportional to the increasing H+ levels. 
When H+ combines with HCO3 during the buffering  process, 
carbonic acid (H2CO3) is formed. Carbonic acid breaks down into 
the end products of carbon dioxide (CO2) and water (H20) in the 
pulmonary capillaries. Although this additional amount of CO2 is 
eliminated into the atmosphere by the lungs, there  comes a point 
at which this system is unable to fend off the developing 
acidosis (Barr, Himwich and Green, 1923). The hydrogen ion level 
increases to a level which is greater than what the bicarbonate 
stores can buffer. 16 
During these instances, the activity of the natural systems is 
not adequate to effect the alkalotic changes needed to maintain 
homeostasis. The bicarbonate reservoir may not be adequate to 
buffer all of the LA formed. Athletes frequently utilize a 
technique called "bicarbonate loading" to supplement this 
process. This technique requires ingestion of buffering 
substances designed to increase blood bicarbonate. This enhances 
the efflux of H+ and lactate from the muscle to the blood. Since 
the muscle membrane is relatively impermeable to sodium 
bicarbonate, buffering primarily occurs in the extracellular fluid 
of the body (Robin, 1961; Goldfinch et al., 1988). Ingestion of 
sodium bicarbonate creates a larger pH gradient across the 
membrane, which facilitates the H+ efflux. By increasing the 
bicarbonate reservoir prior to exercise, blood buffering potential 
is increased (Mainwood & Worsley-Brown, 1975). By increasing 
blood pH and postponing the development of the acidic 
environment, the disruption  in contractile activity, slowing of 
glycolysis, and generation of pain can be delayed. This translates 
into increased endurance, increased power, greater work rates 
accomplished, and delaying of fatigue (Costill, Verstappen, 
Kuipers, Janssen, and Fink, 1984). 
During the performance of a competitive 1600 meter running 
race, energy is supplied via a combination of anaerobic and 
oxidative processes (Fox & Mathews, 1981). Since metabolism 
via anaerobic glycolysis contributes approximately 55% of the 
energy generated, LA accumulation can be a factor in the 
performance. During the performance of this event, runners 17 
approach their VO2max and easily exceed the point at which LA
 
begins to accumulate (Farrell et al., 1979). When this happens, it 
contributes to the onset of fatigue and decrease the performance 
ability (Haverty, Kenney, and Hodgson, 1988). 
Fatigue 
Fatigue represents a reduction in performance secondary to 
the preceding work performed. It reflects a decrease in the 
energy supply necessary to meet the metabolic demands of the 
activity, an increase in metabolic end products, activation of 
central processes such as frustration and boredom, staleness, or 
decreased motivation, or a combination of all these factors. The 
central parameters involve a subjective component which may 
impact the outcome of the performance. Examples of these 
subjective parameters include: mood states, perceived exertion, 
and pain threshold. Asmussen (1979) reports that central fatigue 
results in lowered arousal and a reduction in the amount of 
voluntary effort output. Kirkendall (1990) relates  it to a change 
in the level of motivation. In the 1600 meter run it appears that 
a combination of increases in LA and the individual's pain 
tolerance are factors which may limit the performance. 18 
Ergogenic aids 
For many years scientists have been studying methods to 
manipulate the normal physiological response to work in order to 
delay the onset of fatigue and subsequently enhance performance. 
Substances or procedures which enhance exercise performance 
are referred to as "ergogenic aids". For decades, strategies 
designed to accomplish this goal have been utilized in virtually 
all activities. Strategies geared at making desired changes in the 
energy utilization activity of the LA system have focused on 
increasing plasma and muscle pH values. By minimizing the 
occurrence of acidosis, the normal physiological and chemical 
interactions can proceed optimally. The use of buffering 
substances have facilitated the attainment of this desired pH 
level. 
As early as 1923, Hill & Lupton proposed that using agents 
designed to buffer H+ could counteract the fatiguing effects of 
intense short-term exercise. During this type of activity, as the 
LA level rises, pH drops in the muscle and blood. In this acidic 
environment, glycolysis is slowed (Goldfinch et al.,  1988), the 
muscle contractile mechanism is temporarily impaired 
(Mainwood & Worsley-Brown, 1975), and performance 
deteriorates. 
Ingestion of buffering substances serves to create an 
alkalinizing effect within the blood. Since the muscle membrane 
is impermeable to the buffering substances, the majority of 
buffering occurs in the extracellular environment. By increasing 19 
the bicarbonate concentration in the blood, the efflux of H+ and
 
LA from the muscle is enhanced (Robin, 1961; Mainwood & 
Worsley-Brown, 1975). The disruptions associated with the 
formation of lactic acid become less pronounced. Sodium 
bicarbonate and sodium citrate have been cited as buffering 
agents and have demonstrated some promising ergogenic 
potential. 
Sodium bicarbonate 
As stated previously, increasing the alkalinity of the blood 
assists in neutralizing the strong metabolic acids produced 
during intense exercise. Sodium bicarbonate (NaHCO3) has been 
demonstrated to effectively achieve this during intense 
anaerobic exercise lasting greater than 30 seconds in duration. 
Results from many studies suggest that this may result in 
increased performance. Dennig, Talbott, Edwards, and Dill (1931), 
in a treadmill running study, determined that subject 
performance did improve when exercise commenced following 
alkalosis induced by ingestion of NaHCO3. In the study, the 
subject ingested substances designed to produce either an 
alkalotic or acidotic internal environment. Ten grams of sodium 
bicarbonate was administered in a single dose to facilitate 
alkalosis, and one dose of 15 grams of ammonium chloride 
(NH4CI) was used to attain the acidotic state. 
In each condition, the exercise began once the desired 
internal environment was achieved. The researchers evaluated 20 
the duration of the run and the speed of the run under the
 
conditions of acidosis, alkalosis, and control. They determined 
that the subjects' performance improved following alkalosis 
induced by ingestion of NaHCO3, as demonstrated by longer run 
times as compared to the control or acidotic condition. In the 
acidotic condition, subjects demonstrated a reduction of 
approximately 25% in duration of the performance of the running 
activity compared to normal, and a reduced capacity for oxygen 
debt. Performance terminated following 15 minutes of activity 
during the acidotic condition, while run times ranging from 18­
20 minutes were noted during the other conditions. In this study, 
it appeared that the alkalosis condition may have neutralized the 
increase in acidity which occurred during the exercise, while the 
acidosis condition resulted in reduced LA buffering capacity. 
Simmons and Hardt (1973) studied the effects of the 
ingestion of alkalizing substances on 5 highly trained sprint and 
3 distance swimmers. The swimming distance selected for the 
sprinters was 100 meters, and for the distance swimmers it was 
400 meters. Swim times for all subjects were assessed at a pre­
test and 4 swim tests, all which were carried out at one-week 
intervals. The swimmers were assigned into either an 
experimental or a control group. The alkali substances used in 
the study included 0.715 grams of sodium citrate, 0.5 grams of 
sodium bicarbonate, and 0.215 grams of potassium citrate mixed 
into non-carbonated soft drinks. The control condition used 1.43 
grams of sucrose mixed into the non-carbonated soft drink liquid. 21 
Results indicated that the buffering conditions led to 
significantly better performances in sprint swimming than those 
performances of the control condition for all subjects. This was 
evidenced by significantly faster swim times for the 100 meter 
distance. However, the extent of improvement may have been 
limited in the trained subjects by the fact that these individuals 
already had an increased buffer capacity, secondary to their 
specific training regimen. No comparisons were made concerning 
the distance swimmers, as illness forced one of the three 
subjects to leave the study. 
Wilkes et al. (1983) studied 6 trained male middle-distance 
runners performing in an 800 meter treadmill race following 
ingestion of 0.3 g/kg body weight of NaHCO3, ingestion of 0.3 
g/kg of a placebo (calcium carbonate), or in a control condition. A 
large volume of water was consumed following the ingestion 
conditions. Racing times significantly improved following 
ingestion of NaHCO3 compared to those of the control and placebo 
conditions. Performance time improved in the experimental 
condition compared to the control condition by an average of 2.9 
seconds. An average improvement of 2.2 seconds was noted in the 
experimental condition compared to the placebo condition. LA, 
pH, and bicarbonate concentrations were all higher in the 
experimental group compared to the control and placebo groups 
at the completion of the race. These results were consistent 
with those of Dennig and his colleagues. 
In a similar study by Goldfinch et al. (1988), 6 highly trained 
male 400 meter runners served as subjects. All subjects 22 
ingested 0.4 g/kg of NaHCO3 during the experimental condition of 
the study. Performance was enhanced during the experimental 
phase as measured by significantly faster run times following 
induced alkalosis compared to either the placebo or control 
condition. Subjects posted a mean run time that was 1.52 
seconds faster in the experimental condition compared to either 
of the other conditions. Post-exercise bicarbonate and pH levels 
were significantly higher during this condition compared to the 
control and placebo condition. 
Sutton et al. (1981), in a study of 5 male subjects performing 
exercise on a bicycle ergometer, reported similar findings. Each 
subject participated in a total of three data collection sessions, 
in which they received one of three substances per session. The 
substances which were randomly assigned included: NaHCO3 to 
facilitate the alkalosis condition; CaCO3 for the control 
condition; and NH4CI for the acidosis condition. Substances were 
administered in a dose of 0.3 g/kg body mass and ingested over a 
3 hour period prior to exercise. 
Subjects performed continuous 20 minute exercise bouts on 
the cycle ergometer at 33% and 66% VO2 max. The subjects then 
performed until exhaustion at 95% VO2 max. Results indicated 
that endurance time until exhaustion at the 95% intensity was 
significantly longer in the induced alkalosis condition compared 
to both other conditions. Subjects were able to pedal for an 
average of 48 and 131 seconds longer following NaHCO3 
ingestion compared to the control and acidosis conditions, 
respectively. 23 
Horswill et al. (1988), in a study of 9 endurance trained male 
cyclists performing 2 minute sprint tests on an isokinetic 
bicycle ergometer, found no improvement in performance after 
ingestion of NaHCO3. Subjects performed one 2-minute sprint 
test on 4 separate occasions spaced a minimum of 5 days apart, 
and the total work performed was measured. One hour prior to 
each test, subjects consumed one of 4 solutions administered in 
random fashion. The solutions included: a placebo consisting of 
400 ml of a flavored drink; and flavored drink solutions 
containing either 0.1, 0.15, or 0.2 g/kg body weight of NaHCO3. 
Results indicate that post-exercise bicarbonate levels were 
significantly higher after consuming NaHCO3 compared to 
placebo, and was proportional to the dose administered. However, 
performance was not enhanced, as the total work performed was 
not significantly different in any condition.  It  is possible that 
the lack of improvement in performance was due to the fact that 
the duration of the event was not long enough to maximize the 
buffering effects associated with manipulation of the anaerobic 
glycolytic system, or the doses administered were inadequate. 
The researchers selected the doses used in the study in an 
attempt to minimize the potential for GI discomfort reported in 
other studies using higher doses. The results of this study 
support previous research by Wilkes et al. (1983), which indicate 
that ingestion of NaHCO3 in doses equal to or greater than 0.3 
g/kg body mass is necessary to realize ergogenic potential. 
Approximately 50% of the subjects participating in the 
Wilkes et al. study experienced GI symptoms secondary to 24 
bicarbonate ingestion. Symptoms such as diarrhea, GI discomfort, 
and nausea were reported hours after ingestion of the substance. 
Similar GI symptoms were reported by several subjects in the 
Goldfinch et al. (1988) study following the completion of  a 400 
meter run.  It appears that the ergogenic effects are evident in 
activities ranging from 1-4 minutes in duration with ingestion 
of this much bicarbonate, but the side-effects may render this 
strategy impractical for some individuals. 
Not all the results have been as promising. Johnson & Black 
(1953) studied highly trained cross-country runners performing  a 
1.5 mile run. Results indicated no improvement in performance 
following bicarbonate ingestion. The subjects  were administered 
a single dose of 3.5 grams of bicarbonate prior to the event. It is 
plausible that one dose of this quantity was not adequate in 
increasing the buffer reserve, and/or the aerobic nature of this 
event eliminated the need for buffering.  If oxidative metabolic 
processes predominated, then factors other than buffering of LA 
may have determined race performance. 
Sodium citrate 
Sodium citrate has also been used as an ergogenic aid during 
anaerobic exercise in an attempt to facilitate an alkalotic state 
in the body. This leads to a reduction in the H+ concentration, 
improved buffering of LA, and increases in HCO3 and pH similar 
to that of NaHCO3 (Parry-Billings & Mac Laren, 1986; Kowalchuk, 
Maltais, Yamaji, and Hughson, 1989). Mc Naughton and Cedaro 25 
(1992) suggest that sodium citrate ingestion has an ergogenic 
benefit during cycling activities lasting from 2 to 4 minutes. 
Their research involved investigating the ergogenic benefit of 
sodium citrate ingestion in ten healthy college-aged students 
who performed cycling tasks that were of 10, 30, 120, and 240 
seconds in duration. Blood bicarbonate, base excess, and pH 
levels were among the parameters assessed in all subjects. 
Three conditions were used, including an experimental, placebo, 
and control. 
Total work performed and peak power were also assessed. 
Results suggest that 0.5 g/kg body mass of sodium citrate was 
more effective than the placebo, which consisted of 0.3 g/kg 
body weight of CaCO3 plus 0.5 g sodium chloride (NaCL), or the 
control in achieving this potential during the 120 and 240 second 
exercise periods. Peak power increased by an average of 150 
Watts (W) in the experimental condition compared to both the 
control and placebo conditions for the 120 second exercise 
period. An approximate 100 W increase was also noted during the 
240 second period for the experimental condition. Total work 
performed significantly increased in the experimental condition 
for the 120 and 240 second tasks. At 120 seconds, a 10 kilojoule 
(kj) increase was noted compared to the control condition. This 
increased to approximately a 20 kj improvement over control 
during the 240 second trial. 
The researchers indicated that it was the ingestion of this 
alkalizing substance that caused the improvements in 
performance. The ingestion of the sodium citrate succeeded in 26 
inducing alkalosis by creating a greater buffering gradient. Blood 
bicarbonate and blood lactate levels were significantly increased 
following citrate ingestion compared to the control and placebo 
conditions. Total work and peak power increased in the 
experimental condition when the duration of the cycling exceeded 
2 minutes. 
Mc Naughton (1990), in a cycling study involving 11 male 
subjects, obtained results that were in support of previous 
citrate research. He also determined that 0.5 g/kg of body mass 
was the most effective dose to achieve enhanced performance. He 
studied the effects of five different doses of sodium citrate 
ingested by the subjects prior to performing maximally on a 
bicycle ergometer for 1-minute exercise bouts. The purpose was 
to determine the most effective dose in terms of enhancing 
performance. Doses selected for study were 0.1 g/kg body mass, 
0.2 g/kg, 0.3 g/kg, 0.4 g/kg, and 0.5 g/kg. Subjects ingested the 
substance approximately 1.5 hours before performance of the 
task. Subjects performed the maximal task for one minute at one 
particular dose on a given day. The control test was always first, 
and was followed by the 5 different doses. The order was 
randomly assigned, and each test occurred at least 2 days, but 
not longer than 5 days, following the previous one. 
Base excess, bicarbonate concentration, and lactate 
concentration were among the parameters analyzed. Total work 
and peak power were the performance variables measured. The 
results indicated that, in this task, no ergogenic benefit was 
realized until the dose ingested reached 0.3 g/kg body mass. At 27 
this point the total amount of work performed (40.62 kj) and 
peak power (1,197 W) significantly increased compared to the 
control condition (35.26 kj, 1,081 W). The 0.5 g/kg dose 
demonstrated significant increases in  total work performed 
(44.63 kj) and peak power (1,306 W) compared to any other dose, 
the placebo condition, and the control condition. The blood 
bicarbonate concentration increased significantly in a linear 
fashion with each increasing dose. Base excess values 
significantly increased compared to the control and placebo 
conditions, and greater improvements were noted with 
increasing amounts ingested. 
The results support the use of sodium citrate as an ergogenic 
aid to maximal anaerobic performance of 1-minute duration. 
Although the mechanism is not completely understood, it appears 
that ingestion increases the blood bicarbonate level similar to 
NaHCO3 ingestion. This creates a larger concentration gradient, 
which leads to enhanced extracellular buffering. Another finding 
from this study suggested that use of sodium citrate did not 
result in reports of symptoms of GI distress. This may represent 
an advantage over NaHCO3. Provided performance outcomes are 
similar, and GI discomfort avoided, sodium citrate ingestion in 
this type of activity may be warranted over sodium bicarbonate 
ingestion. 
Direct comparison of acid-base results between studies 
utilizing buffering agents in attempt to enhance performance is 
difficult, secondary to the use of different blood sampling sites. 
Linderman et al. (1990) compared acid-base measurements 28 
obtained via arterial, arterialized venous, and venous blood 
samples from 10 trained male cyclists performing a maximal 
graded exercise test on a cycle ergometer. Results determined 
that at the end of the exercise period, pH, lactate, and HCO3 
values were similar between arterialized venous blood and 
venous blood samples. Both were significantly different than the 
values obtained using arterial blood. 
At the conclusion of the exercise period, arterial lactate 
levels were higher than either arterialized venous or venous 
blood. Arterial pH and HCO3 levels at the conclusion of exercise 
were lower than venous values. They concluded that the use of 
arterialized venous or venous blood may not accurately reflect 
values found in arterial blood secondary to local tissue 
metabolism, and are not an appropriate substitute. These results 
support previous research by Doll, Keul, and Maiwald (1968). 
However, arterial sampling requires invasive procedures, is 
frequently painful to the subject, and requires the presence of 
trained medical personnel. As it represents a greater risk to the 
subject, the use of arterialized venous or venous blood samples 
are frequently used. 
Arterialized venous blood is obtained by warming the surface 
surrounding the sampling site. By increasing the temperature of 
the skin in this manner, approximately 75% of the arterial blood 
is shunted away from the capillary beds and directed to the 
venous system. Often in a laboratory setting, the body part is 
heated during the performance of the activity using a hair dryer, 
heat lamp, or hot pack device. While appropriate for the 29 
laboratory, this procedure is not practical for studies that 
involve field  testing. 
Horswill et al. (1988), in their study of 9 endurance-trained 
cyclists performing 2-minute sprint tests on a cycle ergometer, 
used arterialized venous blood obtained from a pre-heated 
forearm vein to analyze for lactic acid, pH, and bicarbonate. 
Goldfinch et al. (1988), in a study of 6 trained male 400 meter 
runners used arterialized venous blood obtained from an 
indwelling catheter placed in a dorsal vein of the hand. The blood 
was analyzed for pH, bicarbonate, and blood gas levels. The 
Wilkes et al. (1983) study of male 800 meter runners used  a 
procedure similar to Goldfinch. 
The use of venous blood for analysis is used often as a 
procedure during field studies. Costill et al. (1984), in a sprint 
cycling study, obtained 5 ml blood samples from a forearm vein 
of each subject. The blood samples were obtained pre-ingestion, 
pre-race, and post-race, and included analysis for pH, and 
bicarbonate level. Although, the acid-base values were not 
identical to those obtained via other sampling techniques, they 
were similar and consistent. The acid-base measurements 
obtained provide information concerning the relative change in 
pH, lactate, and HCO3 from blood draw to blood draw. Even though 
the values obtained are different than that obtained via other 
methods, the change in values of these variables render this 
procedure appropriate in many instances. Direct comparison 
between studies using different sites and sampling techniques 
should be avoided as the results may be inaccurate. 30 
In summary, at the 1600 meter distance, the anaerobic
 
glycolytic pathways make the most significant contribution to 
the total energy produced. Increases in LA concentration along 
with other factors, such as pain and impaired muscle contractile 
activity, appear to lead to deterioration of performance in this 
event.  If both agents selected to buffer the increase in H+ 
demonstrate ergogenic potential as compared to the control and 
placebo substances, the subsequent question would be to 
determine if one has a decided advantage over the other in terms 
of performance outcomes. The desired performance enhancing 
benefits must be weighed against the undesirable side-effects of 
ingesting each substance. If one substance demonstrates 
equivalent or better ergogenic potential, and it has fewer side-
effects,  it  is reasonable to consider it to be the ergogenic aid of 
choice. 31 
CHAPTER III 
METHODS 
This study was conducted at Oregon State University, 
Corvallis, Oregon and Pacific University, Forest Grove, Oregon. 
The purpose of the study was to determine if ingestion of either 
sodium bicarbonate or sodium citrate prior to a competitive 
1600 meter race enhanced performance in this high intensity 
activity. Previous research has demonstrated that buffering 
improves performance during anaerobic activities lasting 
approximately 1-2 minutes in duration. This study attempted to 
add to the knowledge base and to determine if either of the 
buffering agents selected have a decided advantage over the 
other in outcome. 
Subjects 
Seven male and five female competitive track athletes served 
as subjects for the study and completed an Informed Consent 
Form and medical questionnaire prior to participation. The 
subjects ranged from 18 to 33 years of age and were considered 
to be competitive runners as they were in training for and 
competing in races at the time of this investigation. Male 
runners were capable of completing this distance in a time 
faster than 5:00 minutes, while female subjects were required 
to be capable of completing this distance in a time better than 32 
6:00 minutes. All subjects were apparently healthy with no 
known history of respiratory, cardiac, or metabolic disease, and 
had not sustained any injury which forced them to miss more 
than 3 scheduled training days in the month prior to data 
collection. 
Instrumentation, 
Maximal oxygen consumption to determine each participant's 
aerobic capacity was assessed using a Sensormedics 2900 
metabolic cart (Yorba Linda, CA). This test for aerobic capacity 
was conducted on a motorized treadmill (Sensormedics, MAX-1) 
which was calibrated for speed and grade prior to testing. 
Assessment of body composition was obtained via the 
hydrostatic weighing technique in a specially designed indoor 
tank with the subjects seated on a chair which was suspended in 
the tank. The tank utilized a custom made suspension type of 
scale (Toledo load cell). A GO-MI 5000 lung function testing 
apparatus was used to measure residual lung volumes. 
The four 1600 meter races each subject participated in were 
conducted on a 400 meter synthetic surface track utilized for 
competitions. The subjects were not subjected to inclement 
weather conditions during the races. The performances were 
measured as the elapsed time to complete the distance using 
accepted track racing standards, with recorded accuracy to 
within one tenth of a second. Blood samples of 50 uL were 
obtained via a standard finger puncture from each participant at 33 
specific intervals of the testing sessions to measure blood 
lactate levels. Blood lactate levels were assessed using a 
(Yellow Springs Incorporated Sport 1500 model, Yellow Springs, 
OH) lactate analyzer. Blood samples of 5 ml were obtained via 
venipuncture using the median cubital vein of each participant to 
assess bicarbonate level and pH. Bicarbonate levels and pH were 
assessed using an AVL model 995 (AVL Inc., Roswell, GA) blood 
gas analyzer. The bicarbonate concentrations, pH, and lactate 
levels were determined prior to beginning the race, and 
immediately upon completion of the race. 
Subjective symptoms were reported via a Subjective 
Symptom Scale (see Appendix B) designed by the researcher. The 
interval scale was administered immediately following the post-
race blood draw. It consisted of identifying the presence of any 
symptoms of GI discomfort that occurred at specific intervals 
during the performance of the race. Symptoms were rated in the 
following manner: not present, mild, moderate, or severe. 
Substances ingested during the treatment sessions included: 
0.4 g/kg of body mass of NaHCO3, 0.5 g/kg of sodium citrate, and, 
as the placebo, an equal number of gelatin capsules filled with 
calcium carbonate as was filled with NaHCO3. Only one treatment 
was administered at each data collection session. The 
substances were administered in gelatin capsule form and taken 
with approximately one liter of water. The order of 
administration of the substances was via a counter-balanced 
double-blind assignment. 34 
Procedures 
Each subject was required to produce evidence ensuring that 
he or she met the criteria for inclusion prior to participation in 
the study. All subjects participated in an aerobic capacity 
assessment, a hydrostatic weighing assessment, and four 
competitive 1600 meter races. The races were scheduled at least 
3 days apart to allow for adequate recovery between each test. 
The four race conditions were assigned in a counter-balanced 
double-blind manner. Conditions selected for analysis included: 
control, placebo (calcium carbonate), sodium bicarbonate, and 
sodium citrate. Following explanation of the procedures and 
completion of a medical questionnaire for screening, informed 
consent was obtained (see Appendix A). 
Laboratory Testing 
On the initial visit, aerobic capacity was determined via a 
maximal oxygen consumption test conducted on the motorized 
treadmill. For male subjects, the treadmill was initially set at a 
6% grade and a speed of 6 miles per hour (mph). Progression was 
as follows: 0.5 mph increases per minute until the subject 
reached a velocity of 9 mph. Following this point the grade was 
increased by 1% per minute until the subject became exhausted. 
For female subjects, the treadmill was initially set at a 6% 
grade and a speed of 5 mph. Speed was increased by 0.5 mph each 
minute until reaching 8 mph. After this point the treadmill 35 
elevation was increased by 1% per minute. The test continued in 
this manner until the subject became too fatigued to continue. 
The test was designed to range from 8 to 12 minutes in duration. 
During the test, the subject breathed room air through a two-
way breathing valve, with the exhaled air conducted through low 
resistance tubing to the metabolic cart. This was to permit 
quantitative analysis of expiratory volumes and concentrations 
of oxygen and carbon dioxide. From this analysis, the volume of 
oxygen consumed can be determined. During the procedure, 
continuous electrocardiographic (ECG) data was collected. 
Present during all data collection sessions were individuals 
certified  in cardiopulmonary resuscitation (CPR). 
During the same session, all subjects underwent a 
hydrostatic weighing procedure to determine body composition. 
The indoor tank contained water approximating body temperature 
(35-37° C). The tank featured a suspension scale and, following 
maximal exhalation, the subject submerged him or herself for a 
period of 2-3 seconds until the underwater weight could be 
recorded. The protocol of taking the average of 3 highest trials 
which were within 0.1 kg, as outlined by Bonge and Donnelly 
(1989), was utilized to estimate the underwater weight. 
Residual volume (RV) was estimated using the neon dilution 
method. Body density could then be calculated by using 
Archimedes' principle as outlined by Goldberg & Buskirk, (1961). 
Once body density was determined, percent body fat was 
calculated by using the Siri Equation. Except for one subject, the 
hydrostatic weighing procedure was performed prior to the test 36 
for aerobic capacity. This was to minimize the effect of fatigue, 
and ensure the subjects could achieve optimal residual volume 
measurements. At subsequent sessions, prior to the 1600 meter 
race, the body weight of each subject was obtained using a 
medical quality scale. 
1600 Meter Field Tests 
Approximately 120 minutes prior to the race on buffering and 
placebo condition days, each subject ingested the assigned 
substance. The pre-determined dose of the prescribed substance 
was encapsulated in gelatin capsules and ingested with one liter 
of water to minimize any symptoms of gastrointestinal distress. 
Subjects were instructed to avoid strenuous activity until the 
race. Approximately 2 hours after ingestion, a 50 uL blood 
sample was obtained from each participant via the standard 
finger puncture method in order to measure blood lactate levels. 
Bicarbonate concentration and pH level was determined via 
analysis of a 5 ml sample of blood obtained via venipuncture 
using the median cubital vein. This procedure was repeated 
immediately following completion of the race. 
Following the initial blood draw, participants proceeded to 
the track where they performed warm-up exercises similar to 
those of their usual routine. Following a 30 minute warm-up 
period, a trained starter called the runners to the starting line 
and began the race in accordance with track racing standards. As 
subjects completed the race, their times were recorded, and they 37 
were led back to the blood draw area where the final blood draw
 
was completed. Blood samples for bicarbonate and pH were 
unable to be obtained during any trial for one subject (Subject 
#10). For this subject, blood samples were obtained at each trial 
via finger punctures, and those samples used to analyze lactate 
values. The subjects were instructed to complete a subjective 
symptom scale in which they reported on the presence and 
severity of symptoms of GI discomfort they experienced during 
specific intervals in the race. The intervals identified by the 
scale were at 400, 800, 1200, and 1600 meters; subjects were 
also instructed to list all symptoms experienced and indicate 
whether they were mild, moderate, or severe in nature (see 
Appendix B). 
In the period of time between testing sessions, subjects 
were strongly encouraged to maintain a consistent pattern of 
training, eating, and sleeping. They were encouraged to refrain 
from a hard training session on the day prior to data collection 
for each trial. They also were asked to note the presence of 
injuries or other factors they perceived to potentially influence 
their performance that session. 
Data Analysis 
The StatView SE+ Graphics computer program (Abacus 
Concepts Inc., Berkeley, CA) was used for statistical analysis of 
the data. The analysis consisted of the calculation of means and 
standard deviations for pH, lactate, and bicarbonate levels at 38 
each measurement interval for each substance ingested. The 
significance of the difference in the means of each was 
determined using a repeated measures analysis of variance 
(ANOVA).  If a significant difference was noted, Newman-Keul's 
multiple range post-hoc test was utilized to isolate the source 
of the difference. A one-factor ANOVA for overall performance 
time versus substance ingested and a one-factor ANOVA for 
symptoms versus substance ingested were performed. 
Significance was accepted at the alpha=.05 level. 39 
CHAPTER IV 
RESULTS AND DISCUSSION 
Results 
Demographic data, percent body fat as assessed via 
hydrostatic weighing, and aerobic capacity (V02 max) data for all 
subjects appear in Table 1. All subjects were considered to be in 
a well-trained state as evidenced by VO2 max values that 
exceeded 60 ml/kg/min for males, and 50 ml/kg/min for female 
subjects.  All subjects had percent body fat values that were 
lower than average for their age and sex. The subjects performed 
the runs grouped into three smaller pools secondary to 
scheduling constraints, and therefore, the entire group did not 
compete at the same times. The first group consisted of five 
subjects (2 male, 3 female); the second consisted of 3 males and 
1 female subject; and the third was composed of 2 males and 1 
female subject. 
Data collection for Group 1 occurred during the months of 
July and August 1994. Group 2 data collection occurred during 
October 1994, and Group 3 participated during November and 
December of that year. Details including means and standard 
deviations regarding environmental conditions can be found in 
Appendix C. Average dry temperature recorded in degrees 
Fahrenheit during the data collection period for Group I was 
79.5°, wet bulb was 68.1°, and conditions were sunny and breezy. 40 
Table 1. Demographic and descriptive subject data
 
Subject Sex  Age  Hgt  Wgt  Body Fat  VO2 max 
(yrs) (in)  (kg)  (%)  (ml/kg/min) 
1  M  31  70.0  70.0  9.8  61.38 
2  M  2 2  73.0  77.0  8.6  67.63 
3  M  18  68.0  63.0  3.4  66.88 
4  M  2 3  73.0  75.0  7.8  65.25 
5  M  26  73.0  71.0  12.7  65.89 
6  M  31  68.0  70.0  6.5*  60.81 
7  M  2 5  66.0  65.0  7.9*  67.40 
Mean  2 5  70.1  70.1  8.1  65.00 
8  F  27  66.0  50.0  9.9  63.51 
9  F  3 3  67.0  51.0  14.9  58.05 
10  F  31  65.0  51.5  12.7  50.61 
1 1  F  2 5  66.0  58.0  6.0  61.67 
12  F  19  63.5  71.0  19.3*  50.90 
Mean  2 7  65.5  56.3  12.6  56.90 
* Obtained using Lange Calipers and the Sum of Seven Skinfold 
Technique (Jackson and Pollock, 1977) 41 
Conditions for Group 2 included: average dry temperature of 55°, 
average wet bulb was 53.25°, with overcast skies and windy 
conditions. Group 3 participated under an average dry 
temperature of 46.25°, mean wet bulb temperature of 44.25°, and 
cool and windy conditions. 
Means and standard deviations for overall performance times 
appear in Table 2. Results from a one-factor Analysis of 
Variance (ANOVA) indicate that there was no significant 
difference between overall performance time and substance 
ingested for the group as a whole (p= 0.99). Bicarbonate ingestion 
resulted in the overall fastest mean performance time with a 
mean of 319.2 seconds, and citrate ingestion led to the slowest 
mean performance time of 321.1 seconds. 
Four of the twelve subjects (33.3%) achieved their best 
performances after ingestion of bicarbonate. However, five of 
the subjects (41.67%) ran their fastest times during the control 
trial in which they did not ingest any substance. One subject 
(8.3%) performed the fastest trial  after ingesting citrate, while 
another subject ran the fastest trial following ingestion of the 
placebo, calcium carbonate. Four of the subjects (33.3%) ran 
their slowest times following ingestion of bicarbonate, 
compared to 25.0% each for citrate and control, and 16.67% for 
placebo. 
Gender comparison via a one-factor ANOVA indicated that 
there was no significant difference in overall performance time 42 
Table 2. Performance times for the 1600 meter run
 
1600 meter  Time (sec) 
Subject 
Control  Placebo  Citrate  HCO3 
1  301.8  293.0  300.2  294.7 
2  308.4  310.3  310.8  306.2 
3  306.1  310.8  307.3  318.1 
4  290.1  296.6  293.3  292.2 
5  321.2  307.0  307.4  294.0 
6  286.3  284.4  304.1  283.5 
7  288.0  296.2  298.5  288.7 
8  344.8  342.7  335.9  335.5 
9  360.9  355.6  354.3  362.6 
10  358.2  366.3  366.2  364.3 
11  331.8  328.0  333.1  328.5 
12  340.1  347.7  342.0  352.0 
Mean  319.8  319.9  321.1  319.2 
SD  27.0  27.3  24.1  30.1 
p=.9986 43 
across any condition for male subjects (p= .73). The HCO3 
condition resulted in the fastest performance time with a 
mean time of 296.8 seconds, while citrate ingestion resulted in 
the slowest overall time, with a mean of 303.1 seconds. For 
female subjects, there was no significant difference in 
performance time for any trial (p= .96). Ingestion of citrate 
resulted in the fastest performance time with a mean of 346.3 
seconds, while the HCO3 condition yielded the slowest overall 
time, with a mean of 350.6 seconds. 
Results from a one-factor ANOVA demonstrated no 
significant differences between substance ingested and severity 
of symptoms of gastrointestinal (GI) discomfort experienced for 
the entire subject group (p=.06). Means and standard deviations 
are presented in Table 3. A score of 0 was given if no symptoms 
were experienced, a score of 1  indicated mild GI symptoms, a 
score of 2 represented moderate symptoms, and a score of 3 
indicated severe symptoms were experienced. Bicarbonate 
ingestion produced the most severe symptoms, with one 
individual (8.3%) reporting severe symptoms including diarrhea 
and gas; three reporting moderate symptoms of bloating, gas, and 
an overall sensation of fullness; and one reporting mild 
symptoms. Citrate ingestion resulted in the greatest number of 
individuals reporting symptoms (50.0%). Three of the six 
subjects who reported symptoms, indicated they experienced 
moderate symptoms such as gas and bloating, while the 
remaining three indicated that they experienced mild gas and 
bloating. Twenty five percent of the subjects reported mild 44 
Table 3. Severity of GI symptoms experienced 
0= no GI symptoms 
1= mild GI symptoms 
2= moderate GI symptoms 
3= severe GI symptoms 
Subject  Severity of GI symptoms 
Control  Placebo  Citrate  HCO3 
1  0 0 0 0 
2  0  1 0 0 
3  0 0  1 0 
4  0 0  2 1 
5  0 0 2 3 
6  0  0 2 0 
7  0 0  0 0 
8  0 1  1 2 
9  1  1 0 2 
10  0 0 2 0 
11  0 0 0 0 
12  0 1 0 0 
Mean  .083  .333  .75  .833 
SD  .289  .492  .866  1.115 
p=.0649 45 
symptoms of GI discomfort following ingestion of placebo, while 
8.33% experienced mild symptoms during the control condition. 
Further analysis, based on gender, of severity of GI symptoms 
reported following ingestion of the substances, indicated that no 
significant difference existed between substance ingested and 
severity of symptoms for the male subjects (p= .09). For female 
subjects, the one-factor ANOVA also did not identify any 
significant differences (p=.17). 
Pre-race acid-base values were within normal ranges in all 
conditions for pH and HCO3, and slightly elevated in all 
conditions for lactate. A one-factor ANOVA for pre-race values 
compared to substance ingested determined that there was no 
difference in pre-race mean lactate values in any condition. 
Bicarbonate levels indicate that ingestion of certain substances 
led to significantly higher pre-race HCO3 values (p=.0006). Post-
hoc analysis using the Newman-Keuls multiple range test to 
isolate the source of the difference determined that both the 
bicarbonate and the citrate ingestion led to significantly higher 
HCO3 levels compared to placebo and control conditions at the 
beginning of the race. 
Pre-race pH values indicated that a significant treatment 
effect existed (p=.0399). Post-hoc analysis using the Newman-
Keul procedure failed to isolate the source of the difference. 
However, ingestion of citrate resulted in the highest pre-race pH 
value at 7.381. This was closely followed by ingestion of HCO3 at 
a value of 7.379. The control condition exhibited the lowest pre-
race value of 7.318. Based on the operational definitions used in 46 
this study, alkalosis was achieved in both of the buffering 
conditions. Results of pre-race blood values versus substance 
ingested are presented in Table 4. 
Repeated measures ANOVA indicated that there was a 
significant exercise (p=.0001) but no treatment effect for 
lactate level (p=.945). The performance of the exercise directly 
influenced lactate values and caused them to increase from the 
pre-race to post-race condition. The nature of the activity 
suggests that LA accumulated in the muscle and blood. There 
were significant exercise (p=.0001) and treatment effects for pH 
(p=.0423). During the performance of the 1600 meter run, the 
blood became more acidic as pH declined secondary to LA 
accumulation. Ingestion of HCO3 led to the highest post-race pH 
value at 7.173, followed by citrate at 7.159; placebo at 7.095; 
and control at 7.09. Newman-Keul's multiple range post-hoc 
analysis was unable to isolate the source of the difference 
(Table 4). 
Repeated measures ANOVA indicated a significant exercise 
(p=.0001) and treatment effect for bicarbonate (p=.0005). 
Reductions in HCO3 values were noted from pre-race to post-
race in  all conditions. Post-hoc analysis using the Newman-Keuls 
multiple range test indicated the significant difference was 
between the control and citrate ingestion condition (see Table 4). 47 
Table 4. Acid-base results for the 1600 meter run (Mean i SD) 
# indicates exercise effect (p<.05)
 
% indicates treatment effect (p<.05)
 
t indicates exercise and treatment effect (p<.05)
 
Variable  Condition 
control 
citrate 
HCO3 PH 
placebo 
control 
citrate 
lactate  HCO3 
(mmo1/1)  placebo 
control 
citrate 
HCO3  HCO3 
(mmo1/1)  placebo 
Measurement time 
Pre-race  Post-race 
7.318  (.038)  7.090 (.087)# 
7.381  (.064)  7.159 (.077)# 
7.379  (.055)  7.173 (.087)# 
7.348  (.064)  7.095 (.130)# 
1.801  (1.324)  13.478 (3.404)# 
1.753  (0.715)  14.331  (3.752)# 
1.813  (1.005)  13.897 (4.793)# 
1.826  (0.808)  14.620 (5.154)# 
28.255  (1.576)  14.355 (3.551)# 
31.709  (0.932)%  17.891 (3.222)t 
32.082  (3.263)%  17.427 (3.519)# 
29.682  (2.404)  15.336 (2.341)# 48 
Discussion 
Although physiological values found post-race in the present 
study concerning pH, lactate levels, and bicarbonate levels were 
similar to those cited in previous research, there was no 
improvement in overall performance time noted in this study. 
Previous research (Wilkes et al., 1983; Goldfinch et al., 1988) 
found significant improvements in performance time and 
buffering capacity following ingestion of NaHCO3 at the 800 
meter and 400 meter distance, respectively. In the Wilkes et al. 
study (1983) of trained 800 meter runners, subjects ran an 
average of 2.9 seconds faster following ingestion of NaHCO3 
compared to the control condition, and 2.2 seconds faster than 
compared to the placebo condition. The dose used in the present 
study was equivalent to the one used by Wilkes et al. 
A similar study by Goldfinch et al. (1988) of 6 trained male 
400 meter runners determined that ingestion of NaHCO3 resulted 
in an improvement of performance time by an average of 1.52 
seconds compared to either the control or placebo condition. The 
dose used in their study, 0.4 g/kg, was equivalent to that used in 
the present study. In the present study, there was an average 
improvement in performance time of 0.6 seconds following 
ingestion of NaHCO3, and an average reduction in performance of 
1.3 seconds following ingestion of citrate compared to the 
control condition. One can speculate that since the 1600 meter 
distance does not emphasize anaerobic glycolysis as a means to 
generate energy to the extent that races of 400 and 800 meter 49 
distances do, maximal ergogenic potential is not realized in the 
1600 event. Oxidative processes contribute a greater amount to 
the total energy production as the duration of the exercise period 
is extended beyond 4 minutes. 
The lack of significant improvement in overall performance 
time is consistent with the results found by Johnson & Black 
(1953). Their study consisted of trained cross country runners 
performing a 1.5 mile run either during the control condition or 
after ingestion of a single 3.5 g dose of NaHCO3. In the Johnson & 
Black study,  it  is probable that the lack of improvement was 
attributable to the inadequate size of the dose administered 
and/or the distance of the race. In the present study, the race 
was of a longer distance than those studied by either Wilkes or 
Goldfinch. Previous research (Kindermann et al., 1977) suggests 
that ingestion of at least 0.3 g/kg is necessary to enhance 
performance. In the current study, a dose of 0.4 g/kg was used. 
In the present study, only one subject (Subject #5) 
demonstrated a substantial improvement in time after ingestion 
of NaHCO3. He improved by 11.0 seconds over his next fastest 
time following ingestion of a total of 28.2 grams. However, this 
same subject reported that he had severe symptoms of diarrhea 
during the warm-up period and just prior to the run. 
Of the four subjects who ran their slowest times following 
ingestion of NaHCO3, the decrement in performance compared to 
their next slowest time exceeded 4 seconds. In three out of the 
four,  it exceeded 6 seconds and, for all practical purposes, took 
them out of contention in the race. Three of the four reported no 50 
symptoms of GI discomfort, while the fourth indicated she had 
moderate symptoms of intestinal cramping during the race after 
she ingested 20 grams of NaHCO3. None of the 400 meter 
subjects involved in the Goldfinch et al. (1988) study, and only 
one of the six runners in the Wilkes et al. (1983) 800 meter 
study demonstrated a reduction in performance following 
ingestion of NaHCO3 compared to the control condition. The 
decrease noted in performance of the subject in the Wilkes study 
was only 0.1 second. The results of the present study clearly do 
not support those of previous research concerning ingestion of 
NaHCO3. 
Three individuals ran their slowest times after ingesting 
citrate. Previous research involving ingestion of citrate as an 
ergogenic aid has utilized total work and peak power as the 
measured variables. Therefore, those results do not apply to the 
present study. 
Five of the 12 subjects (41.67%) experienced symptoms of GI 
discomfort following ingestion of HCO3. Of those reporting 
symptoms, 80% rated severity as being moderate or severe. The 
presence of temporary acute discomfort following ingestion of 
HCO3 is consistent with previous work by several researchers 
(Wilkes et al., 1983; Gledhill, 1984; Goldfinch et al., 1988; 
Linderman & Fahey, 1991). In the Wilkes study, 50% of the 
subjects reported symptoms. Linderman and Gosselink (1994) 
indicate that these GI symptoms are secondary to the large 
amount of sodium that needs to be ingested in order to realize an 
ergogenic potential. The ingestion of large quantities of sodium 51 
requires additional fluid to be drawn into the intestine, resulting 
in the presence of the symptoms in some subjects. 
Though a greater number of subjects reported symptoms of GI 
discomfort following citrate ingestion (50%) compared to 
bicarbonate ingestion, the symptoms were not as severe. 
Previous studies indicate that citrate  is normally well tolerated 
by the subjects (Mc Naughton, 1990). In the present study, half of 
the participants reported symptoms after citrate ingestion, 
while 25% of the subjects also reported symptoms after 
ingestion of the placebo, and 8% in the control condition. Perhaps 
anxiety concerning the performance of a competitive event led to 
a greater than expected stress response in these subjects. This 
may explain why such a large percentage of the subjects reported 
symptoms following citrate ingestion, as the results differ from 
those of previous research. 
Results from the acid-base variables indicate that, as 
expected, blood lactate levels demonstrated dramatic increases 
following completion of the event compared to prior to the run. 
Likewise, post-race pH values were significantly lower than pre-
race values. Since this racing distance necessitates a significant 
contribution from anaerobic glycolysis to generate the energy 
necessary to power the activity, lactic acid accumulates in the 
muscle and blood, and the environment becomes more acidic. 
These results are consistent with previous research 
(Mc Naughton, 1990), that suggests this is due to the anaerobic 
nature of the activity, and implicates it as the major cause of 
fatigue in this type of event. 52 
Repeated measures ANOVA indicated a significant exercise 
(p=.0001) and treatment effect for bicarbonate level (p=.0005). 
Reductions in HCO3 values were noted from pre-race to post-
race in  all conditions. Post-hoc analysis indicated that the 
significant difference was between the control and citrate 
condition. Analysis of the pre-race blood sample for HCO3 
indicated that both the citrate and bicarbonate conditions were 
significantly higher than the other conditions. These buffering 
conditions served to increase the extracellular buffer reserve 
prior to commencement of the exercise. The results from this 
study are in agreement with previous research (Wilkes et al., 
1983; Gledhill, 1984; Goldfinch et al., 1988). 
It is an expected response for bicarbonate levels to decrease 
from pre-race to post-race as a result of the heavy exercise 
performed in a competitive race such as the 1600 meter run. 
Hermansen & Osnes (1972) suggest that this is due to the LA 
formed during the exercise period. In this type of event, energy is 
supplied via a combination of anaerobic and oxidative processes, 
with anaerobic glycolysis contributing approximately 55% of the 
energy generated (Fox & Mathews, 1981). Due to this, the 
accumulation of LA in the blood and muscle is noted. The results 
of this study support the previous research (Gledhill, 1984). The 
ingestion of a buffering agent may function to maintain 
bicarbonate levels higher for a longer period of time. This 
indicates better ability to buffer as an efflux of H+ ions is noted. 
Hydrogen ions are more readily buffered in the extracellular 
fluid, allowing greater work to be performed before exhaustion. 53 
Direct comparison of acid-base variables between the 
present study and similar previous studies demonstrated 
consistent and similar values for pH found post-race 
(Kindermann et al, 1977; Wilkes et al., 1983; and Goldfinch et al., 
1988). In the present study, post-race pH in the control condition 
was 7.090, in the NaHCO3 condition it was 7.173, and following 
ingestion of citrate  it was 7.159. The Wilkes et al. (1983) study 
of 800 meter runners by comparison found values to be 7.07 for 
the control condition, and 7.18 in the alkalosis condition. 
Goldfinch et al. (1988) found similar pH values post-race in a 
study of 400 meter runners. 
In the Wilkes et al. study, post-race HCO3 and lactate levels 
were slightly lower than in the present study. In the present 
study, lactate values for the control and NaHCO3 conditions were 
13.478 mmo1/1, and 13.897 mmo1/1, respectively. Bicarbonate 
levels for the control and NaHCO3 conditions in the present study 
were 14.355 mmol /l and 17.427 mmo1/1, respectively. In the 
Wilkes study, lactate level for the control and NaHCO3 conditions 
were 12.62 mmo1/1 and 14.29 mmo1/1. Bicarbonate levels found 
post-race in the Wilkes study were 9.9 mmo1/1 in the control 
condition and 14.3 for the alkalotic condition. In that study, the 
use of a slightly smaller dose of NaHCO3 compared to the present 
study may explain the differences in values between the studies. 
Similar results were noted in the Goldfinch study. 
Based on the similar acid-base results obtained from studies 
that were of similar nature, but of shorter duration, one can 
speculate as to why no improvement in performance occurred in 54 
the present study. A plausible explanation is that there was a 
greater reliance on the aerobic system in the present study, and 
buffering was not utilized to the same degree. Factors other than 
LA accumulation may have been responsible for the onset of 
fatigue. Possibly a reduction in the rate of oxidative enzymatic 
activity, or decreases in glycogen levels occurred. Also,  it  is 
possible that the symptoms of GI discomfort experienced by 
many subjects decreased their willingness to perform at as high 
a level of intensity as they may have been capable of. 
Although the subjects were not required to race in inclement 
weather, there was quite a bit of variability in conditions within 
the three groups of subjects. There was an approximate 30 
degree difference in mean dry temperature between Group 1 and 
Group 3. However, conditions were similar across trials within 
each group, and each subject had been regularly training outdoors 
in similar environmental conditions and was acclimatized to 
them. 55 
CHAPTER V 
SUMMARY, CONCLUSIONS, AND
 
RECOMMENDATIONS FOR FUTURE STUDY
 
Summary 
This study was performed to determine if ingestion of sodium 
bicarbonate or sodium citrate resulted in faster performance 
time during a competitive 1600 meter run. Seven male and 5 
female trained track athletes served as subjects. Ages ranged 
from 19 to 33 years. All subjects participated in a total of 4 
competitive 1600 meter races. During each racing session, one of 
the following substances was administered via a counter­
balanced design: sodium bicarbonate; sodium citrate; calcium 
carbonate as the placebo; and one session served as the control. 
Acid-base data were recorded prior to and immediately following 
each race. Overall performance time and severity of symptoms of 
GI discomfort were recorded at the completion of the run. 
Means and standard deviations for overall performance time 
and severity of symptoms were calculated. Ingestion of NaHCO3 
resulted in the fastest overall performance time with a mean of 
319.2 seconds, and citrate ingestion resulted in the slowest 
overall time with a mean of 321.1 seconds. Ingestion of sodium 
citrate resulted in 50% of the participants reporting symptoms 
of GI discomfort. Fewer subjects (41.6%) reported symptoms 
following ingestion of NaHCO3, however, symptoms were 
classified as more severe in nature. There were no significant 56 
differences noted in overall performance time (p=.99) or severity 
of GI symptoms (p.06) experienced for any condition. In this 
study, the ingestion of selected buffering agents did not enhance 
performance in the 1600 meter run. 
A one-factor analysis of variance was used to determine pre-
race acid-base values for each substance. A significant 
treatment effect was noted for pH (p=.039). Compared to the 
control or placebo conditions, ingestion of either buffering agent 
resulted in achievement of an alkalotic state, as pH exceeded 
7.35. Post-hoc analysis using the Newman Keul multiple range 
test failed to isolate the source of the difference. Significant 
increases in bicarbonate values were found pre-race for both 
HCO3 ingestion and citrate ingestion compared to the placebo and 
control conditions (p=.0006). 
Repeated measures analysis of variance was used to 
determine the significance of the difference among the means of 
each blood variable from pre-race to post-race.  A significant 
difference in bicarbonate level was found post-race between the 
control and the citrate condition (p=.0005), with ingestion of 
citrate resulting in a bicarbonate level of 17.891 mmol /l. 
Conclusions 
1. Mean performance time was not significantly different 
between the buffering conditions and the control or placebo 
conditions. This finding does not support the first hypothesis. 57 
2. Blood pH levels were significantly higher in the buffering 
conditions compared to the placebo and control conditions 
following the completion of the run. However, post-hoc analysis 
failed to isolate the source of the difference. This finding 
supports the hypothesis, and therefore, the hypothesis is 
accepted. 
3. Blood lactate concentrations were not significantly 
different across the conditions at the completion of the run. The 
third hypothesis is rejected based on the fact that the findings 
do not support the hypothesis. 
4. The blood bicarbonate level was significantly higher in the 
citrate condition compared to all other conditions following the 
completion of the run. This finding only partially supports the 
fourth hypothesis, as ingestion of one of the two buffering 
agents led to significantly higher post-race values. 
5. Sodium citrate ingestion did not lead to significantly fewer 
symptoms of GI discomfort compared to bicarbonate ingestion. 
The fifth hypothesis is therefore rejected. 
6. There was no significant difference in race time following 
ingestion of sodium citrate compared to ingestion of the other 
substances. This finding does not support the sixth hypothesis. 58 
Recommendations for future study 
To the knowledge of this investigator, there have been only a 
limited number of quantitative studies conducted in which the 
use of selected buffering agents were used in high intensity 
running activities exceeding 2 minutes' duration. The results 
from these few studies have yielded informative  if not 
conflicting results. The need for additional research is evident. 
Suggestions for further study include: 
1. Repeat the same investigation controlling more stringently 
for other behaviors such as diet, sleep, and exercise; and 
compare the results obtained with the results of this 
investigation. Although subjects in the present study were 
encouraged to refrain from difficult training on the day prior 
to data collection, no effort was made to force them to 
change their normal behaviors. 
2. Repeat the present study running all the male subjects 
together in one group, and all the female subjects together in 
one group. This may foster a more competitive racing scenario. 
3. Repeat the same study using a population of subjects 
considered to be more elite runners. 
4. Repeat the present investigation utilizing a larger number of 
subjects, and utilizing different populations of runners. A 59 
power analysis revealed a low power value, secondary to the 
small sample size. 
5. Repeat the present investigation using shorter distances such 
as the 1,000 and 1,200 meter race. The contribution to energy 
production from anaerobic glycolysis would be greater in races 
of this distance compared to the present study, and perhaps 
greater ergogenic potential would be realized. 60 
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APPENDIX A 
INFORMED CONSENT FORM 
The Effect of Selected Buffering Agents on Performance in the
Competitive 1600 Meter Run 
Investigators: Lori Avedisian, M.S., R.P.T.; Arthur Guerra; and Anthony Wilcox, 
Ph.D. 
Purpose: The purpose of this investigation is to study the effect of sodium 
bicarbonate (NaHCO3) ingestion and sodium citrate ingestion by trained track 
athletes on their performance in a competitive 1600 meter race. 
I have received an oral explanation of the study procedures and
understand they entail: 
1 .  Tests of maximal oxygen consumption (V02 max) 
At the beginning of my participation in the study, I will undergo a test of my aerobic 
capacity. The test will be conducted on a motorized treadmill, starting at a slow 
speed and progressing with gradual increases in speed and treadmill elevation until I 
become too fatigued to continue. The test will take approximately 8 to 12 minutes, 
with only the final few minutes being at a high intensity. 
During the test, I will breathe room air through a mouthpiece so that the amount of 
oxygen I am using can be determined. My heart rate will be continuously monitored 
electrocardiographically. Trained laboratory personnel, certified in CPR, will 
administer the exercise tests. 
2.  Body composition test using hydrostatic weighing. 
My body composition (percent body fat) will be determined using an underwater 
weighing procedure in a specially designed indoor tank. Water in the tank will be 
near body temperature (35-379C). Sitting on a chair that is suspended from a 
scale, I will submerse myself following a maximal exhalation, and remain 
underwater for 3-5 seconds while the scale is read. The procedure will be repeated 
5-6 times.  will perform a test to determine my residual volume (volume of air in I 
the lungs following maximal exhalation), which requires me to breathe into a 
spirometer filled with oxygen for a period of 30-60 seconds. Two or three such 
trials will be performed. 
3.  Sixteen hundred meter race tests. 
In order to study the effects of ingesting sodium bicarbonate or sodium citrate on 
1600 meter running performance, I  will run 4 such races against other subjects in 
the study. One of the races will be after ingesting NaHCO3, one will be following 
sodium citrate, one after ingestion of CaCO3, and one will be without any treatment. 
These races will be on a 400 meter synthetic surface track designed for track 
competition, and they will be timed using accepted track racing procedures. The 
races will be scheduled at least five days apart to allow for complete recovery 
between each. Participants will not run during inclement weather. I agree to wear 
standard racing attire, including shoes for these race tests. 67 
4.  Sodium bicarbonate (NaHCO3) treatment, sodium citrate 
treatment and placebo (CaCO3) procedures 
I understand that I will ingest NaHCO3 in a quantity equivalent to 400 mg/kg body 
weight prior to a 1600 meter race. This quantity of NaHCO3 will be encapsulated in 
gelatin capsules, and taken with approximately one liter of water 90-120 minutes 
before the race. I also understand that prior to a separate 1600 meter race, I will 
ingest 500 mg/kg body weight of sodium citrate. The sodium citrate will be 
encapsulated in gelatin capsules as above. I also understand that prior to a separate 
1600 meter race, I will ingest CaCO3 in a manner similar to that of NaHCO3 
ingestion. I will also run another 1600 meter race without prior ingestion of any 
substance. The order of the four races (treatment A, treatment B, placebo, and 
control) used as tests for this study will be randomly assigned and administered in a 
double-blind fashion so that I  will not know which substance I am ingesting. 
5.  Blood Samples 
Blood samples will be taken at three times at each of the four racing sessions. The 
first interval will be approximately two hours prior to the race, the second will be 
immediately prior to the race, and the final interval will be immediately following 
completion of the race. A standard hygienic finger-puncture method using a sterile 
lancet will be used to collect blood samples that will be used to determine blood pH 
and blood lactate levels. A standard venipuncture using the antecubital vein will be 
performed using sterile equipment, to collect blood samples that will be used to 
determine blood bicarbonate concentrations. 
6.  Subjective Symptom Scale 
Immediately after completing each race, I  will be asked to complete a brief survey 
and describe how I physically felt at specific intervals during the race. 
7.  Risks 
There is a remote risk of death associated with the test of maximal oxygen 
consumption. In large, varied populations, this risk is one death per 10,000 tests. 
Since I am from a low risk segment of the population (young and healthy), and will 
be screened to exclude individuals with known symptoms of heart disease, the risk 
is considerably less. Furthermore, trained personnel will be administering the test 
and monitoring me for signs of exercise intolerance. There will be a remote risk of 
injury or death associated with running a one mile race, but this is a level of 
exertion that I am familiar with, since I am an experienced track athlete and 
regularly perform this type of activity. 
Ingestion of sodium bicarbonate may cause temporary gastrointestinal discomfort 
(gas, diarrhea, bloating). The chance of experiencing gastrointestinal symptoms is 
lessened when it is ingested with large quantities of water, which is why I will be 
drinking one liter when I take the dose. The chronic ingestion of sodium has been 
shown to increase blood pressure in some individuals. The dose of NaHCO3 I will take 
will contain 4-6 grams of sodium, an amount similar to the average intake of 
sodium in the average American diet. Since I do not have high blood pressure and 
since this study involves a one-time only consumption of NaHCO3, this dose will not 
pose a health risk to me. 68 
I 
8.  Benefits 
will benefit from my participation by contributing to the understanding of the 
effects of selected buffering agent ingestion on performance during a one mile race, 
which may have implications for competitive performance. I will also gain 
information about my aerobic capacity and percent body fat, which may be useful to 
me in planning my training program. 
Participation in this study will involve participating in one laboratory session 
requiring 45-60 minutes, and four races, each requiring a time commitment of 
approximately two and one-half hours scheduled about five days apart. The initial 
laboratory session will consist of determination of maximal aerobic capacity and a 
test of body composition. On the four racing days, I will report two hours before the 
race so that blood sampling and ingestion of treatment or placebo can occur. I will 
remain for a short period of time following completion of the race to allow for 
collection of blood samples. 
My anonymity will be ensured by assigning me a code number upon entry into the 
study. All data will be recorded using the code number. The list containing the names 
of the subjects and their code numbers will only be available to the researchers in 
the study. I  will not be identified in any way in the presentation or publication of the 
results of the study. 
Persons who have ever had hepatitis B or C, who have tested positive for HIV or any 
AIDS virus, or persons having AIDS should not donate body fluids. Persons at risk 
for getting and spreading any AIDS virus should not participate in this investigation. 
You are at risk is: 
* you are a man who had sex with another man since 1977, even one time. 
* you have shared a needle, even one time, to inject drugs or medication. 
* you have taken clotting factor concentrates for a bleeding disorder such as 
hemophilia. 
* you have ever had a positive test for any AIDS virus or hepatitis B or C or any 
AIDS antibody. 
* you have had sex with any person described above. 
* you have had sex with a male or female prostitute since 1977. 
Questions about the research or any aspects of my participation in it should be 
directed to Dr. Anthony Wilcox (737-5922). I understand that the University does 
not provide a research subject with compensation or medical treatment in the event 
the subject is injured as a result of participation in the research project. 
I have been completely informed and understand the nature and purpose of the 
research project. The researchers have offered to answer any further questions that 
I may have. I understand that my participation in this study is completely voluntary 
and I may withdraw from the study at any time without prejudice or loss of benefits 
to which my participation entitles me. 69 
I have read the foregoing and agree to participate in this study. 
Subject's Signature  Date 
Subject's Address 
Subject's Phone Number 
Investigator's  Signature  Date 70 
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SUBJECTIVE SYMPTOM SCALE 
Subject identification number 
Please indicate the presence and severity of any symptoms of 
gastrointestinal (GI) discomfort that you experienced during the 
1600 meter run today. Please check the appropriate response, 
identify all symptoms you experienced, and identify the severity 
of each symptom by indicating  if  it was: mild, moderate, or 
severe. 
1.  I  did not experience any symptoms of GI discomfort. 
2.  did experience symptoms of GI discomfort during the run. I 
3.  If you did experience symptoms, continue to number 4. 
4. List each of the GI symptoms you experienced, and indicate the 
severity of each using the choices (mild, moderate, or severe). 
5. Try to remember back to the actual run, and describe bow you 
felt physically at the following points in the race: 
400 meters­71 
800 meters­
1200 meters­
1600 meters-
The space below has been provided for you to make any additional 
comments concerning the run. 72 
APPENDIX C
 
SUBSTANCE INGESTED
 
substance ingested during 
subj. 
1 
2 
sex 
M 
M 
design race 1 
(C)  HCO3 
(A)  control 
race 2 
citrate 
placebo 
race 3 
placebo 
citrate 
race 4 
control 
HCO3 
3 
4 
5 
6 
7 
8 
M 
M 
M 
M 
M 
F 
(D) 
(B) 
(A) 
(C) 
(A) 
(A) 
citrate 
placebo 
control 
HCO3 
control 
control 
control 
HCO3 
placebo 
citrate 
placebo 
placebo 
placebo 
control 
citrate 
placebo 
citrate 
citrate 
HCO3 
citrate 
HCO3 
control 
HCO3 
HCO3 
9  F  (D)  citrate  control  placebo  HCO3 
10  F  (C)  HCO3  citrate  placebo  control 
11 
12 
F 
F 
(B) 
(D) 
placebo 
citrate 
HCO3 
control 
control 
placebo 
citrate 
HCO3 
Design 
A 1,2,4,3 
B2,3,1,4 
C 3,4,2,1 
D 4,1,2,3 
A 1,2,4,3 
1=control 
2=placebo (CaCO3) 
3=HCO3 
4=citrate 73 
APPENDIX D 
SUBSTANCE DOSE 
wt.  # placebo  HCO3 dose (g)  citrate dose (g) 
Subject (kg)  capsules (# capsules)  (# capsules), 
1  69.0  18  27.6 (16)  29.0 (16) 
2  78.0  20  31.2 (17)  39.0  (24) 
3  61.0  16  24.4 (14)  30.5  (18) 
4  73.0  19  29.2 (17)  36.5  (22) 
5  70.5  16  28.2 (14)  32.3  (21) 
6  68.0  18  27.2 (16)  34.0  (21) 
7  66.0  15  26.4 (14)  33.0  (17) 
8  50.0  12  20.0 (12)  25.0  (16) 
9  50.0  12  20.0 (11)  25.0  (14)
 
10  51.0  15  20.4 (15)  25.5  (16)
 
11  58.0  15  23.2 (14)  29.0  (16)
 
12  63.5  14  25.4 (13)  31.8  (16)
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ACID-BASE RESULTS
 
HCO3 units=mmo1/1 
lactate  units= mmol /I 
Blood	  Pre-Race  Post-Race 
Subj.  Race	  Values  (A)  (B) 
1  1	  pH  7.431  7.191 
HCO3  33.9  17.2 
lactate  3.6  17.16 
2	  pH  7.489  7.165 
HCO3  32.6  20.7 
lactate  1.92  15.63 
3	  pH  °  7.357  7.113 
HCO3  28.6  10.7 
lactate  1.11  20.61 
4	  pH  7.345  7.127 
HCO3  29.5  20.2 
lactate  1.35  13.44 
2  1  pH  7.405  7.143 
HCO3  30.9  18.9 
lactate  5.31  14.91 
2  pH  7.347  7.088 
HCO3  26.1  16.2 
lactate  1.56  15.18 
3  pH  7.405  7.143 
HCO3  33.3  19.7 
lactate  1.92  17.52 
4  pH  7.337  7.153 
HCO3  33.8  21.9 
lactate  3.21  16.11 75 
ACID-BASE RESULTS
 
HCO3 units= mmol /I 
lactate  units= mmol /l 
Blood  Pre-Race  Post-Race 
Subj. Race  Values  (A)  (B) 
3  1  pH  7.393  7.064 
HCO3  31.0  10.8 
lactate  2.52  18.21 
2  pH  7.324  7.058 
HCO3  28.2  8.6 
lactate  1.20  19.98 
3  pH  7.359  7.021 
HCO3  34.1  12.6 
lactate  1.50  21.69 
4  pH  7.335  7.041 
HCO3  28.4  13.0 
lactate  0.99  12.694 
4  1  pH  7.322  7.028 
HCO3  27.4  13.4 
lactate 
2  pH  7.415  7.171 
HCO3  35.7  15.7 
lactate  16.70 
3  pH  7.326  7.091 
HCO3  27.9  12.3 
lactate  0.90  11.99 
4  pH  7.363  7.143 
HCO3  31.6  16.1 
lactate  0.65  19.20 
5  1  pH  7.352  7.156 
HCO3  27.2  11.6 
lactate 
2  pH  7.380  7.026 
HCO3  31.80  14.80 
lactate 
3  pH  7.392  7.157 
HCO3  29.9  15.7 
lactate  1.74  18.16 
4  pH  7.445  7.140 
HCO3  31.5  11.7 
lactate  1.10  22.56 76 
ACID-BASE RESULTS
 
HCO3 units=mmo1/1 
lactate  units=mmol/L 
Blood  Pre-race  Post-race 
Subj. Race  Values  (A)  (B) 
6  1  pH  7.381  7.021 
HCO3  36.5  17.4 
lactate  1.08  20.34 
2  pH  7.319  7.111 
HCO3  32.1  19.2 
lactate  1.71  11.94 
3  pH  7.319  6.881 
HCO3  31.9  15.9 
lactate  1.83  20.13 
4  pH  7.293  6.919 
HCO3  29.4  14.8 
lactate  1.26  16.5 
7  1  pH  7.2  7.013 
HCO3  30.2  11.8 
lactate  3.09  16.77 
2  pH  7.244  7.051 
HCO3  31.3  15.0 
lactate  2.58  16.41 
3  pH  7.272  7.074 
HCO3  32.3  17.0 
lactate  3.27  16.65 
4  pH  7.271  7.182 
HCO3  31.9  23.0 
lactate  3.21  12.60 
8  1  pH  7.324  7.071 
HCO3  27.6  18.2 
lactate  1.03  11.17 
2  pH  7.393  7.226 
HCO3  27.3  17.7 
lactate  0.85  7.71 
3  pH  7.470  7.313 
HCO3  30.9  21.5 
lactate  1.11  9.87 
4  pH  7.459  7.277 
HCO3  31.5  19.9 
lactate  1.17  8.96
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ACID-BASE RESULTS
 
HCO3 units=mmo1/1 
lactate  units=mmo1/1 
Blood  Pre-race  Post-race 
Subj.  Race  Values  (A)  (B) 
9  1  pH  7.407  7.283 
HCO3  31.8  18.9 
lactate  0.90  10.05 
2  pH  7.360  7.267 
HCO3  25.8  14.1 
lactate  0.70  7.80 
3  pH  7.481  7.394 
HCO3  29.2  17.2 
lactate  0.93  9.8 
4  pH  7.366  7.308 
HCO3  26.0  15.1 
lactate  1.088  6.94 
10  1  pH 
HCO3 
lactate  1.55  7.94 
2  pH 
HCO3 
lactate  1.49  8.18 
3  pH 
HCO3 
lactate  2.80  8.18 
4  pH 
HCO3 
lactate  1.64  10.26 
11  1  pH  7.362  7.120 
HCO3  30.1  16.8 
lactate  3.21  14.49 
2  pH  7.371  7.240 
HCO3  34.7  19.8 
lactate  1.32  12.78 
3  pH  7.322  7.094 
HCO3  27.6  15.1 
lactate  1.77  13.11 
4  pH  7.356  7.172 
HCO3  32.1  21.5 
lactate  1.59  12.96
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ACID-BASE RESULTS
 
HCO3 units=mmo1/1 
lactate  units= mmol /l 
Blood  Pre-Race  Post-Race 
Subj.  Race  Values  (A)  (B) 
12  1  pH  7.324  7.122 
HCO3  31.2  15.7 
lactate  2.22  13.6 
2  pH  7.271  7.063 
HCO3  26.5  12.3 
lactate  1.56  12.33 
3  pH  7.262  7.096 
HCO3  28.7  18.4 
lactate  1.89  12.00 
4  pH  7.360  7.180 
HCO3  29.0  17.0 
lactate  1.62  14.79 79 
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PERFORMANCE TIME RESULTS
 
Performance Time (min:sec) at 
Subj.  Race 400(m)  800(m)  1200(m)  1600(m) 
1  1  1:09.9  2:27.4  3:44.7  4:54.7 
2  1:10.0  2:29.0  3:48.0  5:00.2 
3  1:10.1  2:25.0  3:40.9  4:53.0 
4  1:13.8  2:30.2  3:46.4  5:01.8 
2  1  1:13.3  2:31.0  3:52.0  5:08.4 
2  1:10.7  2:26.7  3:48.9  5:10.3 
3  1:14.5  2:31.3  3:50.4  5:10.8 
4  1:11.5  2:28.1  3:47.3  5:06.2 
3  1  1:11.0  2:31.4  3:50.5  5:07.3 
2  1:14.9  2:31.9  3:51.2  5:06.1 
3  1:14.5  2:31.3  3:50.4  5:10.8 
4  1:12.3  2:31.0  3:52.4  5:18.1 
4  1  1:08.2  2:27.8  3:43.8  4:56.6 
2  1:09.8  2:24.6  3:40.9  4:52.2 
3  1:11.3  2:25.8  3:40.7  4:50.1 
4  1:13.7  2:28.7  3:43.6  4:53.3 
5  1  1:08.4  2:25.4  3:55.8  5:21.2 
2  1:12.1  2:27.5  3:47.7  5:07.0 
3  1:12.2  2:30.2  3:51.1  5:07.4 
4  1:13.4  2:28.9  3:43.8  4:54.0 
1  1:08.3  2:19.8  3:33.4  4:43.5 
2  1:09.5  2:26.1  3:46.9  5:04.1 
3  1:07.9  2:18.6  3:32.1  4:44.4 
4  109.5  2:22.6  3:35.8  4:46.3 80 
PERFORMANCE TIME RESULTS
 
Performance time (min:sec) at 
Subj.  Race 400 (m) 
7  1  1:08.5 
2  1:09.9 
3  1:08.7 
4  1:10.2 
8  1  1:25.2 
2  1:23.5 
3  1:25.8 
4  1:22.7 
9  1  1:25.6 
2  1:23.8 
3  1:27.6 
4  1:28.3 
10  1  1:26.3 
2  1:25.2 
3  1:26.6 
4  1:28.3 
11  1  1:19.1 
2  1:18.8 
3  1:19.9 
4  1:25.1 
1 2  1  1:18.3 
2  1:15.6 
3  1:18.2 
4  1:22.2 
800 (m) 
2:20.4 
2:24.9 
2:22.3 
2:23.4 
2:50.3 
2:49.5 
2:51.2 
2:47.0 
2:54.3 
2:53.5 
2:58.7 
2:59.8 
2:58.0 
2:59.8 
2:57.9 
2:59.8 
2:43.5 
2:44.7 
2:43.5 
2:50.0 
2:47.0 
2:43.2 
2:50.5 
2:53.3 
1200 (m) 
3:34.0 
3:42.5 
3:40.4 
3:37.9 
4:16.0 
4:17.0 
4:15.3 
4:11.5 
4:26.0 
4:27.6 
4:29.1 
4:31.2 
4:34.2 
4:36.4 
4:31.7 
4:31.2 
4:06.3 
4:12.3 
4:08.6 
4:11.8 
4:16.5 
4:14.7 
4:22.7 
4:26.7 
1600 (m) 
4:48.0 
4:56.2 
4:58.5 
4:48.7 
5:44.8 
5:42.7 
5:35.9 
5:35.5 
5:54.3 
6:00.9 
5:55.6 
6:02.6 
6:04.3 
6:06.2 
6:06.3 
5:58.2, 
5:28.0 
5:38.5 
5:31.8 
5:33.1 
5:42.0 
5:40.1 
5:47.7 
5:52.0 81 
APPENDIX G
 
HYDROSTATIC WEIGHING RESULTS
 
Subj.	  Dry wt.  Ht.  UW wt.  RV  Temp  Body Fat 
(Ibs)  (in)  (Ibs)  (I)  (° C)  ( %) 
1  154.0  69.0  3.72  1.60  3 4  9.8
 
2  173.0  73.0  4.02  2.22  3 6  8.6
 
3  139.0  68.0  3.94  1.43  3 6  3.4
 
4  164.0  73.0  4.40  1.64  3 6  7.8
 
5  157.0  72.5  3.18  1.85  3 6  12.7
 
6  153.5  70.0  6.5*
 
7  144.0  69.0  7.9*
 
8  110.0  66.0  2.50  1.29  3 6  9.9
 
9  113.0  67.0  1.82  1.52  3 7  14.9
 
1 0	  113.5  65.5  6.16  1.49  3 7  12.7 
1 1  128.0  66.5  2.98  1.89  3 6  6.0 
12  157.0  68.0  19.3* 
* Obtained via Lange calipers using the Sum of Seven Skinfold 
Technique (Jackson & Pollock, 1977). 82 
APPENDIX H
 
ENVIRONMENTAL CONDITIONS
 
Group  Trial  Dry Temp  Wet bulb  Conditions 
(°F)  (°F) 
1  81.0  67.5  Sun, breezy 
1  2  77.0  67.0  Sun, breezy 
3  85.5  71.5  Sun 
4  74.5  66.5  Sun, breezy 
Mean  79.5  68.1 
SD  3.8  1.5 
1  54.0  57.0  Windy 
2  2  48.0  50.0  Windy, overcast 
3  57.0  53.0  Windy, overcast 
4  61.0  53.0  Clear, breezy 
Mean  55.0  53.3 
SD  4.0  1.9 
1  52.0  49.0  Clear, sunny 
3  2  43.0  39.0  Cool, windy 
3  42.0  39.0  Cool, windy 
4  48.0  50.0  Drizzle,  mild 
Mean  46.3  44.3 
3.8  5.3 